Engel Law PLLC is investigating whether fair value to Option Care shareholders will result from the proposed merger between Option Care Health, Inc. (NASDAQ: OPCH) and Amedisys, Inc. (NASDAQ: AMED), pursuant to which Amedisys stockholders will receive 3.0213 shares of Option Care common stock for each share of Amedisys common stock they hold.
The Firm’s investigation concerns:
(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.